Avisi Technologies to Present VisiPlate® 2-year Data at AAO Annual Meeting
Avisi Technologies will present 2-year follow-up data from the VITA Trial of its VisiPlate® Aqueous Shunt at the American Academy of Ophthalmology’s annual meeting. The presentation will detail the long-term efficacy and safety of the device, which is designed to address challenges in glaucoma treatment. Avisi’s research focuses on innovative solutions to improve patient outcomes in vision care.
Avisi’s VITA Trial completes 2-year follow up in primary open angle glaucoma patients Dr. Jonathan S. Myers will report the long-term study data at the poster session of the 2026 American Academy of Ophthalmology (AAO) annual meeting Additional presentations on VisiPlate® Aqueous Shunt…